Swiss National Bank
KRON

Swiss National Bank’s Kronos Bio KRON Stock Holding History

Swiss National Bank’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,000
Closed -$289K – 2766
2022
Q1 		$289K Buy
40,000
+2,900
+8% +$24.7K ﹤0.01% 2661
2021
Q4 		$504K Hold
37,100
– – ﹤0.01% 2664
2021
Q3 		$778K Hold
37,100
– – ﹤0.01% 2496
2021
Q2 		$889K Buy
+37,100
New +$939K ﹤0.01% 2523

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Swiss National Bank's KRON Position: Q2 2022 in Review

Swiss National Bank sold out of Kronos Bio (KRON) in Q2 2022, closing a stake of 40,000 shares — an estimated $289K sold.

Swiss National Bank first reported a position in KRON in Q2 2021 and held it in 4 quarters. The position peaked at $889K in Q2 2021. 93 funds tracked by Wall St. Rank hold KRON as of Q2 2022.

  • Swiss National Bank reported no remaining Kronos Bio position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 40,000 Kronos Bio shares in Q2 2022, an estimated $289K.
  • Swiss National Bank first reported a position in Kronos Bio in Q2 2021 and held it in 4 quarters.
  • Swiss National Bank's Kronos Bio position peaked at $889K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.